CoChat

Obovatol attenuates microglia‐mediated neuroinflammation by modulating redox regulation

Open access
Ock, Jiyeon, Han, Hyung S, Hong, Su H, Lee, So Y, Han, Young‐Min, Kwon, Byoung‐Mog, Suk, Kyoungho · 2010 · British Journal of Pharmacology
Cited by 79

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background and purpose: Obovatol isolated from the medicinal herb Magnolia obovata exhibits a variety of biological activities. Here, the effect of obovatol and its mechanism of action on microglial activation, neuroinflammation and neurodegeneration were investigated. Experimental approach: In microglial BV‐2 cells stimulated with lipopolysaccharide (LPS), we measured nitric oxide (NO) and cytokine production, and activation of intracellular signalling pathways by reverse transcription‐polymerase chain reaction and Western blots. Cell death was assayed in co‐cultures of activated microglia (with bacterial LPS) and neurons and in LPS‐induced neuroinflammation in mice in vivo. Key results: Obovatol inhibited microglial NO production with an IC 50 value of 10 µM. Obovatol also inhibited microglial expression of proinflammatory cytokines and inducible nitric‐oxide synthase, which was accompanied by the inhibition of multiple signalling pathways such as nuclear factor kappa B, signal transducers and activators of transcription 1, and mitogen‐activated protein kinases. In addition, obovatol protected cultured neurons from microglial toxicity and inhibited neuroinflammation in mice in vivo. One molecular target of obovatol in microglia was peroxiredoxin 2 (Prx2), identified by affinity chromatography and mass spectrometry. Obovatol enhanced the reactive oxygen species (ROS)‐scavenging activity of Prx2 in vitro, thereby suppressing proinflammatory signalling pathways of microglia where ROS plays an important role. Conclusions and implications: Obovatol is not only a useful chemical tool that can be used to investigate microglial signalling, but also a promising drug candidate against neuroinflammatory diseases. Furthermore, our results indicate that Prx2 is a novel drug target that can be exploited for the therapeutic modulation of neuroinflammatory signalling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.00659.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 79

Metadata

Authors
Ock, J., Han, H. S., Hong, S. H., Lee, S. Y., Han, Y., Kwon, B., & Suk, K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2010-03-29
Volume
159
Issue
8
Pages
1646-1662
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1771347155
Cited by
79
References
7
FWCI
4.24
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obovatol attenuates microglia‐mediated neuroinflammation by modulating redox regulation. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00659.x
The paper
Ock, J., Han, H. S., Hong, S. H., Lee, S. Y., Han, Y., Kwon, B., & Suk, K. (2010). Obovatol attenuates microglia‐mediated neuroinflammation by modulating redox regulation. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00659.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.